AdaptHealth Corp. (NASDAQ:AHCO) Shares Sold by Peregrine Capital Management LLC

Peregrine Capital Management LLC decreased its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 0.3% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 541,428 shares of the company’s stock after selling 1,867 shares during the quarter. Peregrine Capital Management LLC’s holdings in AdaptHealth were worth $5,414,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Innealta Capital LLC purchased a new position in AdaptHealth during the second quarter worth about $101,000. Allspring Global Investments Holdings LLC purchased a new position in shares of AdaptHealth during the 2nd quarter worth approximately $113,000. Bank of New York Mellon Corp lifted its holdings in shares of AdaptHealth by 2.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 746,211 shares of the company’s stock valued at $7,462,000 after buying an additional 20,599 shares during the period. SummerHaven Investment Management LLC boosted its stake in shares of AdaptHealth by 2.7% in the second quarter. SummerHaven Investment Management LLC now owns 57,645 shares of the company’s stock valued at $576,000 after buying an additional 1,503 shares in the last quarter. Finally, Blue Trust Inc. acquired a new position in AdaptHealth during the second quarter worth $85,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Royal Bank of Canada restated an “outperform” rating and set a $13.00 target price on shares of AdaptHealth in a research report on Monday, August 12th. Truist Financial reissued a “buy” rating and set a $13.00 price objective on shares of AdaptHealth in a report on Wednesday, May 15th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $10.70.

AdaptHealth Stock Down 0.7 %

AdaptHealth stock opened at $10.99 on Friday. AdaptHealth Corp. has a fifty-two week low of $6.37 and a fifty-two week high of $12.44. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.11 and a current ratio of 1.33. The stock’s fifty day moving average is $10.37 and its two-hundred day moving average is $10.13. The firm has a market capitalization of $1.46 billion, a price-to-earnings ratio of -2.09, a price-to-earnings-growth ratio of 0.76 and a beta of 1.10.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). The company had revenue of $805.98 million for the quarter, compared to analyst estimates of $802.62 million. AdaptHealth had a positive return on equity of 8.47% and a negative net margin of 21.45%. The company’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.16 earnings per share. Analysts predict that AdaptHealth Corp. will post 0.82 EPS for the current fiscal year.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.